NCI Dictionary of Cancer Terms
The search textbox has an autosuggest feature. When you enter three or more characters, a list of up to 10 suggestions will popup under the textbox. Use the arrow keys to move through the suggestions. To select a suggestion, hit the enter key. Using the escape key closes the listbox and puts you back at the textbox. The radio buttons allow you to toggle between having all search items start with or contain the text you entered in the search box.
anti-TGF-beta monoclonal antibody GC1008 (AN-tee ... BAY-tuh MAH-noh-KLOH-nul AN-tee-BAH-dee ...)
|A substance being studied in the treatment of breast cancer that has spread to other parts of the body. It is also being studied in the treatment of other cancers and conditions. Anti-TGF-beta monoclonal antibody GC1008 binds to a protein called transforming growth factor-beta (TGF-beta), which is found on some cancer cells. Anti-TGF-beta monoclonal antibody GC1008 may help keep cancer cells from growing and prevent the growth of new blood vessels that tumors need to grow. It is a type of monoclonal antibody and a type of antiangiogenesis agent. Also called fresolimumab and GC1008.|